Teva/Ivax merger
This article was originally published in The Tan Sheet
Executive Summary
FTC continues to review the consent order signed by Teva Pharmaceutical and Ivax; however, the firms have "no reason to believe that the acceptance will not be forthcoming shortly," the two firms announce Jan. 10. The acquisition of Ivax by Teva is expected close on the third business day following the firms' announcement that FTC has accepted the order, they add. The deal previously was expected to close Jan. 12, and now is anticipated to close "later this month." The acquisition was announced in August (1"The Tan Sheet" Aug. 1, 2005, p. 11)...
You may also be interested in...
Teva Broadens Private Label OTC Offerings With Ivax Acquisition
Teva's planned acquisition of Ivax adds a wide range of private label OTCs to the firm's generic drug portfolio
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.